User profiles for José Luis Marín-Rubio
José Luis Marín-RubioMemorial Sloan Kettering Cancer Center Verified email at mskcc.org Cited by 197 |
[HTML][HTML] The role of macrophage scavenger receptor 1 (MSR1) in inflammatory disorders and cancer
J Gudgeon, JL Marín-Rubio, M Trost - Frontiers in Immunology, 2022 - frontiersin.org
Macrophage scavenger receptor 1 (MSR1), also named CD204, holds key inflammatory roles
in multiple pathophysiologic processes. Present primarily on the surface of various types …
in multiple pathophysiologic processes. Present primarily on the surface of various types …
Proteomics characterisation of the L929 cell supernatant and its role in BMDM differentiation
BMDMs are a key model system to study macrophage biology in vitro. Commonly used
methods to differentiate macrophages from BM are treatment with either recombinant M-CSF or …
methods to differentiate macrophages from BM are treatment with either recombinant M-CSF or …
Comparison of quantitative mass spectrometric methods for drug target identification by thermal proteome profiling
Thermal proteome profiling (TPP) provides a powerful approach to studying proteome-wide
interactions of small therapeutic molecules and their target and off-target proteins, …
interactions of small therapeutic molecules and their target and off-target proteins, …
CYLD in health and disease
JL Marín-Rubio, I Raote, J Inns… - Disease Models & …, 2023 - journals.biologists.com
CYLD lysine 63 deubiquitinase (CYLD) is a ubiquitin hydrolase with important roles in immunity
and cancer. Complete CYLD ablation, truncation and expression of alternate isoforms, …
and cancer. Complete CYLD ablation, truncation and expression of alternate isoforms, …
[HTML][HTML] FADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications
JL Marín-Rubio, L Vela-Martín, J Fernández-Piqueras… - Cancers, 2019 - mdpi.com
FADD was initially described as an adaptor molecule for death receptor-mediated apoptosis,
but subsequently it has been implicated in nonapoptotic cellular processes such as …
but subsequently it has been implicated in nonapoptotic cellular processes such as …
The E3 ubiquitin ligase RNF115 regulates phagosome maturation and host response to bacterial infection
O Bilkei‐Gorzo, T Heunis, JL Marín‐Rubio… - The EMBO …, 2022 - embopress.org
Phagocytosis is a key process in innate immunity and homeostasis. After particle uptake,
newly formed phagosomes mature by acquisition of endolysosomal enzymes. Macrophage …
newly formed phagosomes mature by acquisition of endolysosomal enzymes. Macrophage …
[HTML][HTML] Technical report: Targeted proteomic analysis reveals enrichment of atypical ubiquitin chains in contractile murine tissues
T Heunis, F Lamoliatte, JL Marín-Rubio, A Dannoura… - Journal of …, 2020 - Elsevier
Ubiquitylation is an elaborate post-translational modification involved in all biological
processes. Its pleotropic effect is driven by the ability to form complex polyubiquitin chain …
processes. Its pleotropic effect is driven by the ability to form complex polyubiquitin chain …
A Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Assay Identifies Nilotinib as an Inhibitor of Inflammation in Acute Myeloid Leukemia
JL Marin-Rubio, RE Peltier-Heap… - Journal of Medicinal …, 2022 - ACS Publications
Inflammatory responses are important in cancer, particularly in the context of monocyte-rich
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …
aggressive myeloid neoplasm. We developed a label-free cellular phenotypic drug discovery …
S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma
JL Marín-Rubio, E Pérez-Gómez… - …, 2019 - academic.oup.com
T-cell lymphoblastic lymphoma is a haematological disease with an urgent need for reliable
prognostic biomarkers that allow therapeutic stratification and dose adjustment. The scarcity …
prognostic biomarkers that allow therapeutic stratification and dose adjustment. The scarcity …
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T‐cell neoplasms
…, H Alarcón, JL Marín‐Rubio… - British Journal of …, 2023 - Wiley Online Library
Despite the Janus kinase/signal transducers and activators of transcription (JAK/STAT)
pathway being frequently altered in T‐ALL/LBL, no specific therapy has been approved for T‐ALL/…
pathway being frequently altered in T‐ALL/LBL, no specific therapy has been approved for T‐ALL/…